---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-111203"
form_type: "8-K"
ticker: "BIO"
cik: "0000012208"
company_name: "BIO-RAD LABORATORIES, INC."
filed_at: "2022-04-20T23:59:59+00:00"
generated_at: "2026-06-26T06:05:49.694142+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Bio-Rad amends credit agreement to exclude cash over $200M from leverage ratio

## Summary
- Amendment No. 2 redefines Leverage Ratio to deduct cash and cash equivalents exceeding $200M from total funded debt.
- Section 6.1 reporting deadlines extended: annual financials to 120 days (from 90) and quarterly to 60 days (from 45).
- Amendment effective April 15, 2022; no defaults or new borrowing; lenders include JPMorgan, Bank of America, HSBC, and others.

## SEC filing metadata
- accession: 0001193125-22-111203
- form_type: 8-K
- ticker: BIO
- cik: 0000012208
- company_name: BIO-RAD LABORATORIES, INC.
- filed_at: 2022-04-20T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/12208/000119312522111203/0001193125-22-111203-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/12208/000119312522111203/d321252d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-111203
- JSON: https://secwatch.observer/filing/0001193125-22-111203.json
- Plain text: https://secwatch.observer/filing/0001193125-22-111203.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.